Exemestane and Meldonium Interaction

Monitor
Mechanism-based 47% confidence

Exemestane and Meldonium have an interaction requiring monitoring for interaction with 47% confidence. Both Exemestane and Meldonium negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Both compounds affect the heart, so monitoring these systems is recommended.

Compound Profiles

Exemestane

Steroidal Aromatase Inhibitor | Irreversible Estrogen Control

Exemestane functions as a mechanism-based (suicide) inhibitor of aromatase (cytochrome P450 19A1). Due to its steroidal structure, exemestane is recognized by aromatase as a substrate analogue and enters the enzyme's active site.

Half-life: ~24 hours Typical dose: 12.5mg EOD or 25mg E3D (estrogen management) pct, anabolic
androgen receptoraromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Meldonium

Metabolic Modulator | Endurance & Cardioprotection

Meldonium exerts its primary pharmacological effect by inhibiting gamma-butyrobetaine hydroxylase (BBOX), the enzyme responsible for the final step in the biosynthesis of L-carnitine from gamma-butyrobetaine (GBB). By competitively blocking this enzyme, meldonium reduces endogenous carnitine production, which in turn lowers intracellular carnitine concentrations over time.

Half-life: ~4-6 hours Typical dose: 500-1000 mg/day cardiovascular, metabolic
epo receptor blood pressure raisingcardiotoxiclipid disruptingteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Heart
moderate
Liver
moderate
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds disrupt lipids (Exemestane, Meldonium). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Exemestane, Meldonium). Monitor accordingly.

Frequently Asked Questions

Can I take Exemestane with Meldonium?

Yes, but with caution. Both Exemestane and Meldonium negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. Regular monitoring is advised.

Is Exemestane and Meldonium safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between Exemestane and Meldonium?

Both Exemestane and Meldonium negatively affect lipid profiles. Combined use may significantly worsen HDL/LDL ratios. Include lipid support and get bloodwork mid-cycle. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Exemestane and Meldonium?

Exemestane has a half-life of ~24 hours and Meldonium has a half-life of ~4-6 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Exemestane vs Meldonium

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.